Munich Re's Profit Surge of 56% Meets Investor Skepticism as Shares Hit 12-Month Low

Munich Re record Q1 profit, shares at 12-month low. Analysts see 25% upside but pricing fears. Technical RSI suggests oversold. Catalyst: CFO speech June 2-3.

Munich Re is posting record numbers, yet its stock is plumbing depths not seen in a year. The contradiction could hardly be starker: first-quarter net income surged 56 percent to €1.714 billion, but the shares closed on Friday at €452.80 — their lowest level in 12 months, a full 25 percent below the 52-week high of €605.

The sell-off accelerated in May, when the stock tumbled 14.44 percent, making it the worst performer in the DAX. The rout has left the shares 17.5 percent in the red since January and 22 percent lower than a year ago. Even the €2.25 billion share buyback programme, the first tranche of up to €900 million now underway, has failed to stem the bleeding.

Analysts, however, see a disconnect worth exploiting. The eight banks that have recently rated the reinsurer assign a median price target of €564.57, implying upside of roughly 25 percent from current levels. But the consensus is stuck at "hold" or "neutral". Barclays Capital holds an "overweight" rating with a €575 target, while Goldman Sachs late last month trimmed its target from €568 to €557, keeping a "neutral" stance.

The market's anxiety centres on pricing. In the April renewal season, Munich Re deliberately turned away business that did not meet its return thresholds, shrinking its written premium volume by 18.5 percent to €2.0 billion. Risk-adjusted prices fell 3.1 percent on average, and the entire sector has felt the chill — Hannover Re lost nearly 11 percent in May. The company insists the quality of its portfolio held up, but investors will need reassurance that the trend will not worsen in the July renewals.

Against that caution, the operational figures paint a picture of strength. The technical underwriting result climbed to €2.676 billion, while the combined ratio in property/casualty reinsurance improved to 66.8 percent. Major claims dropped to just €130 million. Investment income also contributed, with the reinvestment yield reaching 4.2 percent. The solvency ratio stood at a muscular 292 percent — well above the internal target range of 175 to 220 percent, and after already accounting for the buyback.

Management has repeatedly affirmed its 2026 net profit target of €6.3 billion, and the "Ambition 2030" strategy calls for a return on equity above 18 percent.

Technically, the stock's 71 reading on the relative strength index signals short-term overbought conditions despite the sell-off, hinting at the possibility of a mean-reversion bounce. The next catalyst comes this week when CFO Andrew Buchanan speaks at the Goldman Sachs European Financials Conference in Zurich on June 2-3. Investors will be listening for signals on pricing trends for the second half of the year. Until the half-year report lands on August 7, the market is likely to stay in a waiting mode, caught between record earnings and lingering price jitters.